Financing

Share Buybacks

UnitedHealth Group Share Buybacks decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $3.00B to $0.00. Over 3 years (FY 2021 to FY 2024), Share Buybacks shows an upward trend with a 21.6% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026

How to read this metric

High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.

Detailed definition

The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...

Peer comparison

Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.

Metric ID: share_repurchases

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q1 '26
Value$1.25B$1.05B$1.05B$2.50B$2.50B$1.00B$1.00B$2.00B$3.00B$1.50B$1.50B$3.07B$0.00$956.00M$4.97B$3.00B$2.55B$0.00
QoQ Change-16.0%+0.0%+138.1%+0.0%-60.0%+0.0%+100.0%+50.0%-50.0%+0.0%+104.8%-100.0%+420.1%-39.7%-15.2%-100.0%
YoY Change+100.0%-4.8%-4.8%-20.0%+20.0%+50.0%+50.0%+53.6%-100.0%-36.3%+231.5%-2.3%-100.0%
Range$0.00$4.97B
CAGR-100.0%
Avg YoY Growth+18.2%
Median YoY Growth-2.3%
Current Streak3 quarters decline

Frequently Asked Questions

What is UnitedHealth Group's share buybacks?
UnitedHealth Group (UNH) reported share buybacks of $0.00 in Q1 2026.
How has UnitedHealth Group's share buybacks changed year-over-year?
UnitedHealth Group's share buybacks decreased by 100.0% year-over-year, from $3.00B to $0.00.
What is the long-term trend for UnitedHealth Group's share buybacks?
Over 3 years (2021 to 2024), UnitedHealth Group's share buybacks has grown at a 21.6% compound annual growth rate (CAGR), from $5.00B to $9.00B.
What does share buybacks mean?
Cash spent by the company to buy back its own stock.